← All trials
NCT04902872
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 3, 2021
- Primary completion
- Jan 31, 2024
- Completion date
- Apr 30, 2024
- First posted
- May 26, 2021
- Last posted
- May 28, 2021
- Enrollment
- 112
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cybrexa TherapeuticsLead sponsor
- Cybrexa TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.